Skip to main content
SpringerLink
Log in

Pharmacological adaptations and muscarinic receptor plasticity in hypothalamus of senescent rats treated chronically with cholinergic drugs

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Receptor plasticity is an important compensatory process by which the central nervous system adapts to pathological insult or long-term exposure to drugs. Senescent animals may show an age-related impairment of muscarinic receptor up- or down-regulation after chronic exposure to cholinergic drugs. The purpose of this study was to assess biochemical and pharmacological endpoints of muscarinic receptor plasticity in young, adult and senescent animals. Male, Fischer 344 rats (ages 3, 9, and 27 months) were administered methylatropine or oxotremorine intracerebroventricularly (IVT) for 3 weeks and tested for their functional response to a muscarinic agonist. The density of hypothalamic, muscarinic receptors was also estimated from analysis of 3H-QNB binding isotherms. In young rats, parallel changes in muscarinic receptors and response were noted, but chronic administration of cholinergic drugs to senescent animals had no effect. Thus, 3H-QNB binding in hypothalamus of young and adult rats was increased (31% and 17%) after chronic IVT methylatropine and decreased (20% and 15%) after IVT oxotremorine. Also, young rats treated with IVT methylatropine were supersensitive to the hypothermic effects of a muscarinic agonist (oxotremorine), while young and adult animals administered chronic IVT oxotremorine exhibited marked tolerance. In contrast, identically treated senescent rats showed no changes in 3H-QNB binding or oxotremorine-induced hypothermia. These results demonstrate the impaired ability of senescent rats to up- or down-regulate brain muscarinic receptors and to exhibit functional adaptations seen in young animals treated chronically with cholinergic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bartus RT, Dean RL, Pontecorvo MJ, Flicker C (1985) The cholinergic hypothesis: a historical overview, current perspective and future directions. In: Olton D, Gamzu E, Corkin S (eds) Memory dysfunctions: integration of animal and human research from clinical and preclinical perspectives. New York Acad Sci, New York, pp 332–358

    Google Scholar 

  • Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  • Churchill L, Pazdernik TL, Samson F, Nelson SR (1984) Topographical distribution of down-regulated muscarinic receptors in rat brains after repeated exposure to diisopropyl phosphorofluoridate. Neuroscience 11:463–472

    Google Scholar 

  • Collins AC, Smolen TN, Smolen A, Medhurst LJ (1987) Cross-tolerance between muscarinic agonists: role of muscarinic receptors. Pharmacol Biochem Behav 26:173–182

    Google Scholar 

  • Costa LG, Schwab BW, Murphy SD (1982) Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides. Biochem Pharmacol 31:3407–3413

    Google Scholar 

  • DeLean A, Munson PJ, Rodbard D (1979) Multi-subsite receptors for multivalent ligands. Mol Pharmacol 15:60–70

    Google Scholar 

  • Ehlert FJ, Kokka N, Fairhurst AS (1980) Altered [3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate. Mol Pharmacol 17:24–30

    Google Scholar 

  • Greenberg LH, Brunswick DJ, Weiss B (1985) Effect of age on the rate of recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity. Brain Res 328:81–88

    Google Scholar 

  • Hirschhorn ID, Makman MH, Sharpless NS (1982) Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat. Brain Res 234:357–368

    Google Scholar 

  • Joseph JA, Filburn CR, Roth GS (1981) Development of dopamine receptor denervation supersensitivity in the neostriatum of the senescent rat. Life Sci 29:575–584

    Google Scholar 

  • Joseph JA, Bartus RT, Clody D, Morgan D, Finch C, Beer B, Sesack S (1983) Psychomotor performance in the senescent rodent: Reduction of deficits via striatal dopamine receptor up-regulation. Neurobiol Aging 4:313–319

    Google Scholar 

  • Lerer B (1985) Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry 20:20–40

    Google Scholar 

  • Lerer B, Altman H, McIntyre M, Stanley M (1984) Electroconvulsive shock and brain muscarinic receptors: Relationship to anterograde amnesia. Life Sci 35:2659–2664

    Google Scholar 

  • Majocha R, Baldessarini RJ (1980) Increased muscarinic receptor binding in rat forebrain after scopolamine. Eur J Pharmacol 67:327–328

    Google Scholar 

  • Majocha R, Baldessarini RJ (1984) Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic. Life Sci 35:2247–2255

    Google Scholar 

  • Marks MJ, Collins AC (1985) Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine. Pharmacol Biochem Behav 22:283–291

    Google Scholar 

  • Marks MJ, Artman LD, Collins AC (1983) Quantitation of tolerance development after chronic oxotremorine treatment. Pharmacol Biochem Behav 19:103–113

    Google Scholar 

  • Marks MJ, O'Connor MF, Artman LD, Burch JB, Collins AC (1984) Chronic scopolamine treatment and brain cholinergic function. Pharmacol Biochem Behav 20:771–777

    Google Scholar 

  • McDougal JN, Marques PR, Burks TF (1981) Reduced tolerance to morphine thermoregulatory effects in senescent rats. Life Sci 28:137–145

    Google Scholar 

  • McKinney M, Coyle JT (1982) Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions. J Neurosci 2:97–105

    Google Scholar 

  • Misra CH, Shelat H, Smith RC (1982) Age affects dopamine receptor changes during chronic administration of fluphenazine. Eur J Pharmacol 85:343–346

    Google Scholar 

  • Morin AM, Wasterlain CG (1980) Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding. Neurochem Res 5:301–308

    Google Scholar 

  • Pedigo NW, Polk DM (1985) Reduced muscarinic receptor plasticity in frontal cortex of aged rats after chronic administration of cholinergic drugs. Life Sci 37:1443–1449

    Google Scholar 

  • Pedigo NW, Minor LD, Krumrei TN (1984) Cholinergic drug effects and brain muscarinic receptor binding in aged rats. Neurobiol Aging 5:227–233

    Google Scholar 

  • Pomara N, Stanley M (1986) The functional status of central muscarinic receptors in Alzheimer's disease: assessment and therapeutic implications. In: Crook T, Bartus R, Ferris S, Gershon S (eds) Treatment development strategies for Alzheimer's disease. Powley, Madison, CN, pp 451–467

    Google Scholar 

  • Pradhan SN (1980) Central neurotransmitters and aging. Life Sci 26:1643–1656

    Google Scholar 

  • Randall PK (1984) Lesion-induced DA supersensitivity in aging C57BL/6J mice. Brain Res 308:333–336

    Google Scholar 

  • Randall PK, Severson JA, Finch CE (1981) Aging and the regulation of striatal dopaminergic mechanisms in mice. J Pharmacol Exp Ther 219:690–700

    Google Scholar 

  • Reeves PM, Schweizer MP (1983) Aging, diazepam exposure and benzodiazepine receptors in rat cortex. Brain Res 270:376–379

    Google Scholar 

  • Roth GS (1979) Hormone receptor changes during adulthood and senescence: significance for aging research. Fed Proc 38:1910–1914

    Google Scholar 

  • Russell RW, Carson VG, Booth RA, Jenden DJ (1981) Mechanisms of tolerance to the anticholinesterase, DFP: acetylcholine levels and dynamics in the rat brain. Neuropharmacology 20:1197–1201

    Google Scholar 

  • Russell RW, Ehlert FJ, Hwa JJ (1986) Relation between behaviorally augmented tolerance and upregulation of muscarinic receptors in the CNS: effects of chronic administration of scopolamine. Psychopharmacology 88:33–39

    Google Scholar 

  • Smit MH, Ehlert FJ, Yamamura S, Roeske WR, Yamamura HI (1980) Differential regulation of muscarinic agonist binding sites following chronic cholinesterase inhibition. Eur J Pharmacol 66:379–380

    Google Scholar 

  • Smolen TN, Smolen A, Collins AC (1986) Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP. Pharmacol Biochem Behav 25:1293–1301

    Google Scholar 

  • Spencer PSJ (1965) Activity of centrally acting and other drugs against tremor and hypothermia induced in mice by tremorine. Br J Pharmacol 25:442–455

    Google Scholar 

  • Sutin EL, Shiromani PJ, Kelsoe JR, Storch FI, Gillin JC (1986) Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci 39:2419–2427

    Google Scholar 

  • Takeyasu K, Uchida S, Noguchi Y, Fujita N, Saito K, Hata F, Yoshida H (1979) Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats. Life Sci 25:585–592

    Google Scholar 

  • Taylor JE, Yaksh TL, Richelson E (1982) Agonist regulation of muscarinic acetylcholine receptors in rat spinal cord. J Neurochem 39:521–524

    Google Scholar 

  • Waddington JL, O'Boyle KM, Molloy AG, Youssef HA, King DJ, Cooper SJ (1985) Neurotransmitter receptors in aging: Dopamine-neuroleptic receptors and involuntary movements in the disease process of schizophrenia. In: O'Malley K, Waddington JL (eds) Therapeutics in the elderly: scientific foundations and clinical practice. Elsevier, Amsterdam, pp 63–76

    Google Scholar 

  • Weiss B, Greenberg L, Cantor E (1979) Age-related alterations in the development of adrenergic denervation supersensitivity. Fed Proc 38:1915–1921

    Google Scholar 

  • Westlind A, Grynfarb M, Hedlund B, Bartfai T, Fuxe K (1981) Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment. Brain Res 225:131–141

    Google Scholar 

  • Yamada S, Isogai M, Okudaira H, Hayashi E (1983a) Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. J Pharmacol Exp Ther 226:519–525

    Google Scholar 

  • Yamada S, Isogai M, Okudaira H, Hayashi E (1983b) Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine. Brain Res 268:315–320

    Google Scholar 

  • Zhou LW, Weiss B, Freilich JS, Greenberg LH (1984) Impaired recovery of alpha1- and alpha2-adrenergic receptors in brain tissue of aged rats. J Gerontol 39:538–546

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pharmacology and Anesthesiology, University of Kentucky Medical Center, 40536, Lexington, KY, USA

    Norman W. Pedigo Jr

Authors
  1. Norman W. Pedigo Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pedigo, N.W. Pharmacological adaptations and muscarinic receptor plasticity in hypothalamus of senescent rats treated chronically with cholinergic drugs. Psychopharmacology 95, 497–501 (1988). https://doi.org/10.1007/BF00172962

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172962

Key words

Search

Navigation